Tandem Investment Advisors, Inc. Abb Vie Inc. Transaction History

Tandem Investment Advisors, Inc.

$2.64 Billion
Q3 2024

A detailed history of Tandem Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Tandem Investment Advisors, Inc. holds 9,874 shares of ABBV stock, worth $1.73 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

9,874

Previous 10,851 9.0%

Holding current value

$1.73 Million

Previous $1.86 Million 4.78%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $160,071 - $194,745	-977 Reduced 9.0%	9,874 $1.95 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $22.5 Million - $26.3 Million	-145,294 Reduced 93.05%	10,851 $1.86 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $11.3 Million - $12.9 Million	-70,918 Reduced 31.23%	156,145 $28.4 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $34.5 Million - $38.9 Million	-250,744 Reduced 52.48%	227,063 $35.2 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $19.6 Million - $22.6 Million	-146,443 Reduced 23.46%	477,807 $71.2 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $4.29 Million - $5.34 Million	32,382 Added 5.47%	624,250 $84.1 Million
Q1 2023 Jul 18, 2023	BUY	$144.61 - $166.54 $6.67 Million - $7.68 Million	46,118 Added 8.45%	591,868 $94.3 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $9.29 Million - $11.1 Million	-67,171 Reduced 10.96%	545,750 $88.2 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $4.97 Million - $5.7 Million	37,021 Added 6.43%	612,921 $82.3 Million
Q2 2022 Sep 14, 2022	BUY	$137.62 - $174.96 $8.87 Million - $11.3 Million	64,471 Added 12.61%	575,900 $88.2 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $648,945 - $805,158	4,917 Added 0.97%	511,429 $82.9 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $1.17 Million - $1.48 Million	10,907 Added 2.2%	506,512 $68.6 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $3.42 Million - $3.89 Million	32,177 Added 6.94%	495,605 $53.5 Million
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $3.2 Million - $3.56 Million	30,406 Added 7.02%	463,428 $52.2 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $4.51 Million - $4.97 Million	44,090 Added 11.34%	433,022 $46.9 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $2.92 Million - $3.94 Million	36,236 Added 10.27%	388,932 $41.7 Million
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $3 Million - $3.52 Million	34,953 Added 11.0%	352,696 $30.9 Million
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $1.29 Million - $1.73 Million	17,601 Added 5.86%	317,743 $31.2 Million
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $2.8 Million - $4.24 Million	43,348 Added 16.88%	300,142 $22.9 Million
Q4 2019 Jan 15, 2020	BUY	$72.13 - $90.25 $221,511 - $277,157	3,071 Added 1.21%	256,794 $22.7 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $538,793 - $647,784	8,555 Added 3.49%	253,723 $19.2 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $1.32 Million - $1.68 Million	20,036 Added 8.9%	245,168 $17.8 Million
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $2.67 Million - $3.14 Million	34,599 Added 18.16%	225,132 $18.1 Million
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $884,375 - $1.09 Million	11,360 Added 6.34%	190,533 $17.6 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $931,065 - $1.04 Million	10,472 Added 6.21%	179,173 $16.9 Million
Q2 2018 Jul 05, 2018	BUY	$89.78 - $106.23 $227,233 - $268,868	2,531 Added 1.52%	168,701 $15.6 Million
Q1 2018 Apr 03, 2018	BUY	$92.01 - $123.21 $924,056 - $1.24 Million	10,043 Added 6.43%	166,170 $15.7 Million
Q4 2017 Jan 09, 2018	BUY	$89.56 - $98.21 $14 Million - $15.3 Million	156,127	156,127 $15.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tandem Investment Advisors, Inc. with notifications on news.

Account

Tandem Investment Advisors, Inc. Abb Vie Inc. Transaction History